News about "Clinical Research"

Thermo Fisher Scientific Partners with HealthVerity to Advance Data-Driven Clinical Research

Thermo Fisher Scientific Partners with HealthVerity to Advance Data-Driven Clinical Research

The collaboration between Thermo Fisher Scientific and Healthverity grants enterprise access to one of the largest real-world healthcare datasets, enabling AI-powered insights to improve clinical trials, evidence generation and patient outcomes.

Clinical Research | 15/04/2026 | By News Bureau 119

Okami Medical Enrolls First Patient in ALPHA Registry for LOBO Vascular Occlusion System

Okami Medical Enrolls First Patient in ALPHA Registry for LOBO Vascular Occlusion System

The multicentre study will evaluate the safety and effectiveness of the LOBO device in treating peripheral vascular conditions, with plans to enroll up to 500 patients.

Clinical Research | 08/04/2026 | By News Bureau 107

Sanofi's Lunsekimig Shows Promising Phase II Results in Asthma and Nasal Polyps Studies

Sanofi's Lunsekimig Shows Promising Phase II Results in Asthma and Nasal Polyps Studies

The novel dual-targeting Nanobody met primary and key secondary endpoints in asthma and chronic rhinosinusitis trials, demonstrating improved outcomes and a favourable safety profile.

Clinical Research | 08/04/2026 | By News Bureau

Trialt Partners with Viedoc to Streamline Clinical Trials and Enhance Data-Driven Decision-Making

Trialt Partners with Viedoc to Streamline Clinical Trials and Enhance Data-Driven Decision-Making

The strategic collaboration between Trialt Partners and Viedoc integrates biometrics expertise with cloud-based eClinical technology to accelerate timelines and improve data quality across global studies.

Clinical Research | 07/04/2026 | By News Bureau

Iqvia and Duke Clinical Research Institute Partner to Advance Obesity and Cardiometabolic Clinical Trials

Iqvia and Duke Clinical Research Institute Partner to Advance Obesity and Cardiometabolic Clinical Trials

Iqvia and DCRI have formed a strategic collaboration to enhance the design and execution of obesity and cardiometabolic clinical trials, combining global operational capabilities with academic research expertise.

Clinical Research | 12/02/2026 | By News Bureau 155

FIU Researchers Advance Functional Precision Medicine for Hard to Treat Cancers

FIU Researchers Advance Functional Precision Medicine for Hard to Treat Cancers

FIU researchers are advancing functional precision medicine for hard-to-treat cancers, with new funding accelerating drug sensitivity testing to identify personalized, effective therapies beyond conventional genetic approaches.

Clinical Research | 22/01/2026 | By News Bureau 128

Worldwide Clinical Trials to Acquire Catalyst Clinical Research

Worldwide Clinical Trials to Acquire Catalyst Clinical Research

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.

Clinical Research | 21/01/2026 | By News Bureau 263

FDA Publishes Guidance on Modern Statistical Methods for Clinical Research

FDA Publishes Guidance on Modern Statistical Methods for Clinical Research

The FDA guidance provides a framework for applying Bayesian analyses in clinical research, enabling data-driven assessments of safety and efficacy using both current and prior evidence.

Clinical Research | 14/01/2026 | By News Bureau

WHO Report Highlights Major Equity Gaps in Human Genomics Research

WHO Report Highlights Major Equity Gaps in Human Genomics Research

A new WHO analysis highlights major equity gaps in human genomics research, despite rapid growth in the field, with over 6,500 clinical studies registered globally, largely focused on cancer and rare diseases.

Clinical Research | 24/12/2025 | By News Bureau 101

PharmAla Biotech Australia Ties Up with UK CDMO to Manufacture ALA-002

PharmAla Biotech Australia Ties Up with UK CDMO to Manufacture ALA-002

PharmAla Biotech Australia has contracted a UK-based CDMO to manufacture the drug substance for ALA-002, its patented non-racemic MDMA formulation, ahead of planned phase 2a/2b clinical trials for social anxiety disorder expected to begin in 2026.

Clinical Research | 16/12/2025 | By News Bureau 150


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members